http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
송희상,황기철,권기환,Soyeon Lim,강석민,고영국,ZhengZhe Xu,정지형,김병수,이학배,정보영,박성하,최동훈,Yangsoo Jang,정남식,유경종 한국분자세포생물학회 2005 Molecules and cells Vol.19 No.3
Bone marrow mesenchymal stem cells (MSCs) have shown potential for cardiac repair following myocardial injury, but this approach is limited by their poor viability after transplantation. To reduce cell loss after transplantation, we introduced the fibroblast growth factor-2 (FGF-2) gene ex vivo before transplantation. The isolated MSCs produced colonies with a fibroblast-like morphology in 2 weeks; over 95% expressed CD71, and 28% expressed the cardiomyocyte-specific transcription factor, Nkx2.5, as well as α-skeletal actin, Nkx2.5, and GATA4. In hypoxic culture, the FGF-2-transfected MSCs (FGF-2-MSCs) secreted increased levels of FGF-2 and displayed a threefold increase in viability, as well as increased expression of the anti-apoptotic gene, Bcl2, and reduced DNA laddering. They had functional adrenergic receptors, like cardiomyocytes, and exposure to norepinephrine led to phosphorylation of ERK1/2. Viable cells persisted 4 weeks after implantation of 5.0 × 105 FGF-2-MSCs into infarcted myocardia. Expression of cardiac troponin T (CTn T) and a voltage-gated Ca2+ channel (CaV2.1) increased, and new blood vessels formed. These data suggest that genetic modification of MSCs before transplantation could be useful for treating myocardial infarction and end-stage cardiac failure.
시금치종자의 ${\alpha}-glucosidase$에 의한 L-ascorbic acid로부터 ascorbic acid-2-glucoside의 생산
정지윤,송희상,방원기,Chung, Ji-Youn,Song, Hee-Sang,Bang, Won-Gi 한국응용생명화학회 2004 Applied Biological Chemistry (Appl Biol Chem) Vol.47 No.2
Ascorbic acid로부터 $2-O-{\alpha}-D-glucopyranosyl-L-ascorbic$ acid(ascorbic acid-2-glucoside, AA-2G)를 생산하기 위하여, transglucosylation 활성을 가지는 시금치 종자의 ${\alpha}-glucosidase$를 효소원으로 이용하였다. 시금치 종자로 사용한 Spinachia oleracea L. WooSung의 조효소액의 ${\alpha}-glucosidase$ 활성은 발아 후 3일 째에 가장 높게 나타났으며, AA-2G의 생산은 2일 키운 시금치의 조효소액을 이용하였을 때, 생산량이 1.053 mM로 가장 높았다. 조효소액을 이용한 AA-2G 생산에 있어서 glucose 공여체로는 maltose가 가장 좋았으며, maltose와 ascorbic acid의 최적 농도는 각각 225 mM과 175 mM이었다. ${\alpha}-glucosidase$는 60 unit를 사용했을 때 생산량이 가장 좋았다. 효과적인 반응완충용액은 sodium acetate 완충액이었으며, 최적 농도는 175 mM이었다. 최적 pH및 반응온도는 각각 5.0과 $65^{\circ}C$였고, 최적 반응조건 하에서 50분 반응 후에 ascorbic acid로부터 2.30 mM의 AA-2G가 생산되었다. For the production of $2-O-{\alpha}-D-glucopyranosyl-L-ascorbic$ acid (ascorbic acid-2-g1ucoside, AA-2G) from ascorbic acid, the usability of spinach seed as the source of ${\alpha}-glucosidase$ having transglucosylation activity was studied. The optimum conditions for the production of AA-2G from ascorbic acid and glucose donor were investigated by using crude extract of Spinachia oleracea L. Woosung, the selected source of enzyme. The production of AA-2G was the highest with 1.053 mM when spinach seeds were grown for 2 days after germination. Maltose was the most effective glucose donor, and the optimum concentration of ascorbic acid and maltose were 175 mM and 225 mM, respectively. The optimum concentration of ${\alpha}-glucosidase$ was 60 units. The most effective buffer was sodium acetate and its optimum concentration was 175 mM. The optimum pH and temperature were 5.0 and $65^{\circ}C$, respectively. Under the optimum condition, 2.14 mM of AA-2G was produced from ascorbic acid after 50 minutes of reaction.
시금치종자의 a-glucosidase에 의한 L-ascorbic acid로부터 ascorbic acid-2-glucoside의 생산
정지윤,송희상,방원기 한국응용생명화학회 2004 Journal of Applied Biological Chemistry (J. Appl. Vol.47 No.2
For the production of 2-O-α-D-glucopyranosyl-L-ascorbic acid (ascorbic acid-2-glucoside, AA-2G) from ascorbic acid, the usability of spinach seed as the source of α-glucosidase having transglucosylation activity was studied. The optimum conditions for the production of AA-2G from ascorbic acid and glucose donor were investigated by using crude extract of Spinachia oleracea L. Woosung, the selected source of enzyme. The production of AA-2G was the highest with 1.053 mM when spinach seeds were grown for 2 days after germination. Maltose was the most effective glucose donor, and the optimum concentration of ascorbic acid and maltose were 175 mM and 225 mM, respectively. The optimum concentration of α-glucosidase was 60 units. The most effective buffer was sodium acetate and its optimum concentration was 175 mM. The optimum pH and temperature were 5.0 and 65oC, respectively. Under the optimum condition, 2.14 mM of AA-2G was produced from ascorbic acid after 50 minutes of reaction.
임이진,주수진,송희상 한국생약학회 2019 Natural Product Sciences Vol.25 No.2
Ischemia/reperfusion-induced myocardial injury is the main cause of acute myocardial infarction. Dendropanax morbifera Léveille has been used in traditional medicines for the treatment of various diseases such as headache, infectious diseases, and general debility. However, the effect of extract from D. morbifera (EDM) on myocardial ischemic injury is still unknown. In this study, the effects of EDM on neonatal rat cardiomyocytes with hypoxia/reoxygenation (H/R) injury were investigated. The viability of cardiomyocytes with H (30 min)/R (1 h) decreased; however, treatment with EDM significantly inhibited H/R injury-induced cardiomyocyte death. Further, we observed that reactive oxygen species (ROS) generation and intracellular calcium concentration (Ca2+i) were significantly reduced in EDM-treated cardiomyocytes compared with that in H/R-injured positive control. In addition, western blotting results showed that EDM attenuated abnormal changes of RyR2 and SERCA2a genes in hypoxic cardiomyocytes. These results suggest that EDM ameliorates ROS generation and Ca2+i homeostasis to prevent dysregulation of calcium regulatory proteins in the heart, thereby exerting cardioprotective effects and reducing hypoxia-induced cardiomyocyte damage, which verifies the potential use of EDM as a new therapeutic agent for the treatment of myocardial ischemic injury.
Bacillus sp.에 의한 생물계면활성제의 생산 및 그의 성질
김진숙,방원기,정남현,송희상 한국응용생명화학회 2005 Journal of Applied Biological Chemistry (J. Appl. Vol.48 No.2
A bacterium capable of emulsifying hydrocarbon, n-hexadecane, and decreasing surface tension of the culture media using oil collapsing method was isolated. The bacterium was partially identified as Bacillus sp. and named BJS-51. n-Hexadecane was the most effective carbon source for production of biosurfactant. Surface tension was decreased from 76 dyne/cm to 31 dyne/cm and CMD (critical micelle dilution) had the highest value of 5.7 at 3% n-hexadecane. Ammonium phosphate was the most effective nitrogen source, when C/N ratio was 60, surface tension and CMD were 29 dyne/cm and 9.2, respectively. Optimum pH and temperature were 7.2 and 30oC, respectively. Produced biosurfactant was extracted and purified using organic solvent extraction method and preparative HPLC systems. After analysis by various color reaction, this biosurfactant was identified as lipopolysaccharide. Surface tension and CMC (critical micelle concentration) of purified biosurfactant were 27 dyne/cm and 0.08 g/l, repectively. CMD was 9.2, so the yield of biosurfactant was about 0.74 g/l at the optimal conditions. The biosurfactant was very stable at wide range of pH 2~12 with surface tension 29~31 dyne/cm and showed 29~30 dyne/cm of surface tension after heat treatment at 100oC for 60 min. 토양 시료로부터 n-hexadecane 대사능을 가지며 배양액의 표면장력을 감소시키고, 탄화수소를 가장 잘 유화시키는 세균을 oil-film collapsing 방법을 통해 선별하였다. 세균은 Bacillus sp.로 부분동정되었으며, BJS-51로 명명하였다. 생물계면활성제의 최적 생산에는 n-hexadecane이 가장 효과적인 탄소원이었으며, 3%의 농도일 때 표면장력이 76 dyne/cm에서 31 dyne/cm로 감소하였다. 이 때, CMD(critical micelle dilution)가 5.7로 가장 높았다. 질소원으로는 (NH4)2HPO4가 가장 효과적이었으며, C/N ratio가 60인 경우 표면장력이 29 dyne/cm, CMD가 9.2로 가장 활성이 좋았다. 생산 최적 pH는 7.2였으며, 최적 온도는 30oC였다.Bacillus sp. BJS-51에 의해 생산된 생물계면활성제를 유기용매 추출법과 preparative HPLC systems을 통해 추출, 정제하였다.각종 발색 시약으로 정제된 생물계면활성제의 생화학적 성질을 조사한 결과, 지질다당임을 확인 할 수 있었다. 생산된 생물계 면활성제의 표면장력은 27 dyne/cm까지 감소하였으며,CMC(critical micelle concentration)는 0.08 g/l였다. 상기의 최적 조건에서 생물계면활성제의 생산량은 CMD값이 9.2이었으므로 약 0.74 g/l이었다. 생산된 생물계면활성제는 pH 2~12 사이에서 표면장력 29~31 dyne/cm로 안정하였으며, 100℃에서 60분간 열을 가한 후에도 표면장력 29~30 dyne/cm로 안정하였다.
Novel Lactam Type Pyridine Derivatives Improves Myocardium Dysfunction Derived from Ischemic Injury
김경은,최은주,장양수,송희상,차민지,송병욱,함온주,이장연,최성용,이세연,황기철 한국조직공학과 재생의학회 2009 조직공학과 재생의학 Vol.6 No.13
The extended acute myocardial ischemia (AMI) results in cardiac myocytes death. In the present study, we show that lactam pyridine derivative, SK-D80375, have the effects on cell survival in hypoxic cardiomyocytes and might be used as an anti-ischemic drug. The lactam pyridine derivatives are inhibitors of the late sodium current, which decreases sodium-dependent intracellular calcium overload in ischemia/reperfusion-injured hearts. We found that pretreatment with SK-D80375 significantly decreased the level of intracellular Ca2+ and the expression level of the Na+-Ca2+ exchanger by 39±2.5% and 19±0.5%, respectively in hypoxic cardiomyocytes compared to untreated controls. In addition, the expression level of sarcoplasmic reticulum Ca2+ ATPase 2a was significantly increased by 37±1.5% in SK-D80375-treated hypoxic cardiomyocytes compared to untreated controls. The induction of Hsp70 was observed in SK-D80375-treated hypoxic cardiomyocytes with dose-dependent manner and the highest level of Hsp70 was induced at the concentration of 2.5 μM SK-D80375. The echocardiographic analysis showed that heart function was significantly improved in SK-D80375-injected ischemic hearts. These results demonstrate that lactam pyridine derivative, SK-D80375, have beneficial effects on hypoxia-induced cell death, therefore, might be used as a novel anti-ischemia drug.
박성하,조승연,임소연,장우철,송희상,이선주,송병욱,김혜정,차민지,최은주,장양수,정남식,황기철 연세대학교의과대학 2008 Yonsei medical journal Vol.49 No.4
Purpose: Thiazolidinediones (TZDs) are known to inhibit the proliferation of vascular smooth muscle cell (VSMC) by increasing the activity of p27Kip1 and retinoblastoma protein (RB). However, the upstream signaling mechanisms associated with this pathway have not been elucidated. The Akt-mTOR-P70S6 kinase pathway is the central regulator of cell growth and proliferation, and increases cell proliferation by inhibiting the activities of p27Kip1 and retinoblastoma protein (RB). Therefore, we hypothesized in this study that rosiglitazone inhibits VSMC proliferation through the inhibition of the Akt-TOR-P70S6K signaling pathway. Materials and Methods: Rat aortic smooth muscle cells (RAoSMCs) were treated with 10μM of rosiglitazone 24 hours before the addition of insulin as a mitogenic stimulus. Western blot analysis was performed to determine the inhibitory effect of rosiglitazone treatment on the Akt- mTOR-P70S6K signaling pathway. Carotid balloon injury was also performed in Otsuka Long-Evans Tokushima Fatty (OLETF) diabetic rats that were pretreated with 3 mg/kg of rosiglitazone. Results: Western blot analysis demonstrated significant inhibition of activation of p-Akt, p-m-TOR, and p-p70S6K in cells treated with rosiglitazone. The inhibition of the activation of the p-mTOR-p-p70S6K pathway seemed to be mediated by both the upstream PI3K pathway and MEK-ERK complex. Conclusion: The inhibitory effect of rosiglitazone on RAoSMC proliferation in vitro and in vivo is mediated by the inhibition of the Akt-mTOR-P70S6K pathway.